Enhancement of fracture healing in the rat, modulated by compounds that stimulate inducible nitric oxide synthase
Tóm tắt
We investigated the effects on fracture healing of two up-regulators of inducible nitric oxide synthase (iNOS) in a rat model of an open femoral osteotomy: tadalafil, a phosphodiesterase inhibitor, and the recently reported nutraceutical, COMB-4 (consisting of L-citrulline, Paullinia cupana, ginger and muira puama), given orally for either 14 or 42 days.
Unilateral femoral osteotomies were created in 58 male rats and fixed with an intramedullary compression nail. Rats were treated daily either with vehicle, tadalafil or COMB-4. Biomechanical testing of the healed fracture was performed on day 42. The volume, mineral content and bone density of the callus were measured by quantitative CT on days 14 and 42. Expression of iNOS was measured by immunohistochemistry.
When compared with the control group, the COMB-4 group exhibited 46% higher maximum strength (t-test, p = 0.029) and 92% higher stiffness (t-test, p = 0.023), but no significant changes were observed in the tadalafil group. At days 14 and 42, there was no significant difference between the three groups with respect to callus volume, mineral content and bone density. Expression of iNOS at day 14 was significantly higher in the COMB-4 group which, as expected, had returned to baseline levels at day 42.
This study demonstrates an enhancement in fracture healing by an oral natural product known to augment iNOS expression. Cite this article: R. A. Rajfer, A. Kilic, A. S. Neviaser, L. M. Schulte, S. M. Hlaing, J. Landeros, M. G. Ferrini, E. Ebramzadeh, S-H. Park. Enhancement of fracture healing in the rat, modulated by compounds that stimulate inducible nitric oxide synthase: Acceleration of fracture healing via inducible nitric oxide synthase. Bone Joint Res 2017:6:–97. DOI: 10.1302/2046-3758.62.BJR-2016-0164.R2.
Từ khóa
Tài liệu tham khảo
Caplan AI, 1990, Clin Orthop Relat Res, 257
Baldik Y, Clin Orthop Relat Res, 2002, 343
Katsuki S, 1977, J Cyclic Nucleotide Res, 3, 23
Weiss B, 1975, Adv Cyclic Nucleotide Res, 5, 195
Klein-Nulend J, 2014, Osteoporos Int, 25, 1427
Fox SW, 1996, Am J Physiol, 270, E955
No authors listed. Highlight of prescribing information. http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021368s011lbl.pdf (date last accessed 01 December 2016).
Henrie AM, 2015, Core Evid, 10, 99
Gruenwald J. PDR for Herbal Medicines 2nd ed. Montvale, New Jersey Thompson: Medical Economics Co 2000:531-532.